does semaglutide show in blood tests Up Test Results? Labs Before Semaglutide: Complete GLP-1

For instance, Wegovy has been associated with increased heart rate and the potential for gallbladder-related issues, such as gallstones

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two primary indications: type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)

Additionally, the Merck application does not disclose that a peptide-based melanocortin agonist may be administered by an intranasal route and a PDE-5 inhibitor administered by an oral route, or that the agents may be sequentially administered at timed intervals to obtain optimal results

Importantly, Wegovy is not recommended during pregnancy or breastfeeding, and women of childbearing potential should use effective contraception while taking the medication